Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06912854 · ClinicalTrials.gov registry record · NA
Sensory Adapted Dental Environments to Enhance Oral Care for Children With and Without Dental Fear and Anxiety
A NA study of Dental Fear and Anxiety, sponsored by University of Southern California.
- Recruiting
- Registry status
- NA
- Development phase
- 312
- Enrollment target
- 1
- Study location
NCT06912854: Recruiting NA study of Dental Fear and Anxiety, sponsored by University of Southern California.
NCT06912854 is a NA study of Dental Fear and Anxiety that is actively recruiting participants, run by University of Southern California. The registered enrollment target is 312 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06912854, a NA study of Dental Fear and Anxiety, is actively recruiting participants, sponsored by University of Southern California.
- RECRUITING
- Registry status
- NA
- Development phase
- 312 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is a randomized clinical trial investigating the effectiveness of a Sensory Adapted Dental Environment (SADE) alone and together with a video-based modeling (VBM) component (VBM-SADE), compared to a regular dental environment (RDE) and/or VBM alone, to reduce anxiety, distress behavior, pain, and sensory discomfort during a dental cleaning in children with and without dental fear and anxiety.
Primary Outcome
Electrodermal Activity (EDA; skin conductance level \[SCL\]) reflects the activation of the sympathetic 'fight or flight' nervous system and is well-documented to increase in stressful or painful situations. A BIOPAC MP160 System will be used to record the child's EDA. The child will relax in dental chair for three minutes in order to obtain a resting baseline EDA measurement, followed by EDA recording for the duration of the dental cleaning.
Conditions Studied
Interventions
- OTHER Sensory Adapted Dental Environment
- OTHER Video-based Modeling
Study Locations (1)
California
- Children's Hospital Los Angeles - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 312 participants |
| Start Date | 2025-05-09 |
| Est. Completion | 2029-03 |
| Phase | NA |
What NCT06912854 shows while recruiting
NCT06912854 is an interventional study that assigns participants to a tested intervention. The registered 312 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (78% lower).
The record links to 1 condition, with Dental Fear and Anxiety appearing as the primary indexed condition, and to 2 interventions - of which Sensory Adapted Dental Environment is the first listed.
NCT06912854 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06912854 about?
NCT06912854 is a clinical study titled "Sensory Adapted Dental Environments to Enhance Oral Care for Children With and Without Dental Fear and Anxiety". This study is a randomized clinical trial investigating the effectiveness of a Sensory Adapted Dental Environment (SADE) alone and together with a video-based modeling (VBM) component (VBM-SADE), compared to a regular dental environment (RDE) and/or VBM alone, to reduce anxiety, distress behavior, p...
What is the current status of trial NCT06912854?
This trial is currently recruiting. It is a NA study. The enrollment target is 312 participants. The study started on 2025-05-09. Estimated completion is 2029-03.
What conditions does trial NCT06912854 study?
This clinical trial studies the following conditions: Dental Fear and Anxiety.
What interventions are being tested in trial NCT06912854?
The interventions under investigation include: Sensory Adapted Dental Environment (OTHER), Video-based Modeling (OTHER).
Who is sponsoring clinical trial NCT06912854?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06912854 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06912854's enrollment target sits among peer trials
312 323rd of 2000 higher than 1,678 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04984551 · 312 participants · Phase 2
Impact of Project ECHO on Improving the Quality of Palliative Care in Patients With Advanced Cancer and Their Caregivers in Underserved Areas of Kenya, Nigeria, Ghana, South Africa, India, and Ethiopia
- NCT04999904 · 312 participants · NA
A Proprioceptive Training Program Using an Uneven Terrain Treadmill for Patients With Ankle Instability
- NCT05220332 · 312 participants · NA
Church-based Intervention to Improve Blood Pressure in African Americans
- NCT05434234 · 312 participants · Phase 1
A Study of YL201 in Patients With Advanced Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI